메디채널

공유하기

Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity

2025.07.15 07:00:00

많이 본 기사

더보기

섹션별 최근기사
섹션별 인기기사

경제Ant Digital Technologies's Jovay Launches Testnet, Mainnet launch expected in Q4
엔터Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience
라이프Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience
스포츠The Westin Singapore Presents "Mind Over Miles" Fireside Chat to Celebrate Third Year with Standard Chartered Singapore Marathon
정치2025 YF Life Jr. Astronauts Set to Embark on U.S. Space Exploration Journey
사회'Will' Takes Off in Taiwan and Launches 'Low-Sugar Strawberry Flavor' New Product Thanks to Local Popularity

발행인 : 최희정 | 편집인 : 김갑성 | 등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 | 주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동) Copyright @메디채널 Corp. All rights reserved.